Pharma Journalist - Page 99 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

AVEROA Wins EU Approval for XOANACYL Oral CKD Therapy

Echosens and Boehringer Ingelheim Expand Partnership to Advance MASH Diagnosis and Care

SpliceBio Raises $135M Series B to Advance SB-007 for Stargardt Disease

Capsida to Begin Phase 1/2 Trial of CAP-003 in Q3

Novo Nordisk Advances Amycretin for Weight Loss to Phase 3 Trials

BioNTech to Acquire CureVac in Strategic Public Exchange Deal

FDA Approves MAVYRET as First Treatment for Acute Hepatitis C

Enhancing Collaboration: Networking Opportunities at the Summit

FDA Approves Merck’s ENFLONSIA for RSV Prevention in Infants

YolTech Therapeutics Gets FDA Green Light for Gene-Editing Therapy YOLT-101 for HeFH